Douglas J. Ringler

Keine laufenden Positionen mehr

Health Technology

Consumer Services

Profil

Douglas J.
Ringler was the founder of LeukoSite, Inc. (founded in 1993) and Tolerx, Inc. (founded in 2000), where he held the title of Scientific Officer and President & Chief Executive Officer, respectively.
He also has an undergraduate and doctorate degree from the University of Pennsylvania.

Ehemalige bekannte Positionen von Douglas J. Ringler

Unternehmen	Position	Ende
Tolerx, Inc. Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA.	Gründer	19.12.2011
LeukoSite, Inc. LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA.	Gründer	01.01.1998

Sehen Sie sich die Erfahrung von Douglas J. Ringler im Detail an

Ausbildung von Douglas J. Ringler

University of Pennsylvania

Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Douglas J. Ringler im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Tolerx, Inc. Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA.	Health Technology
LeukoSite, Inc. LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA.	Health Technology